Zapping away chemo pain: new device trial offers hope

NCT ID NCT07151963

ENROLLING_BY_INVITATION Symptom relief Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a non-invasive brain stimulation technique called prolonged continuous theta burst stimulation (pcTBS) to relieve nerve pain caused by chemotherapy in breast cancer patients. Forty women will receive either pcTBS or standard repetitive transcranial magnetic stimulation (rTMS) in a crossover design. The goal is to see which method better reduces pain, depression, and anxiety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: prolonged continuous theta burst stimulation (pcTBS) device
What this could lead to: If it works, this could offer a non-drug way to reduce nerve pain and improve mood in breast cancer survivors with chemotherapy side effects.
What could go wrong: This is a small, early-stage crossover trial with only 40 people. The effect may be modest or not last, and results may not apply to all cancer types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm chemotherapy-induced neuropathy female breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER FEMALES

Contacts and locations

Locations

Taipei Tzu Chi Hospital

New Taipei City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.